Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

NYSE:EXK - New York Stock Exchange, Inc. - CA29258Y1034 - Common Stock - Currency: USD

4.81  +0.01 (+0.21%)

After market: 4.8 -0.01 (-0.21%)

Fundamental Rating

3

Taking everything into account, EXK scores 3 out of 10 in our fundamental rating. EXK was compared to 155 industry peers in the Metals & Mining industry. EXK may be in some trouble as it scores bad on both profitability and health. EXK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year EXK has reported negative net income.
EXK had a positive operating cash flow in the past year.
Of the past 5 years EXK 4 years were profitable.
In the past 5 years EXK always reported a positive cash flow from operatings.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.68%, EXK is doing worse than 69.03% of the companies in the same industry.
EXK has a Return On Equity of -13.98%. This is in the lower half of the industry: EXK underperforms 66.45% of its industry peers.
With a Return On Invested Capital value of 1.17%, EXK perfoms like the industry average, outperforming 48.39% of the companies in the same industry.
EXK had an Average Return On Invested Capital over the past 3 years of 2.76%. This is significantly below the industry average of 11.10%.
Industry RankSector Rank
ROA -8.68%
ROE -13.98%
ROIC 1.17%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

Looking at the Operating Margin, with a value of 4.23%, EXK is in line with its industry, outperforming 54.84% of the companies in the same industry.
In the last couple of years the Operating Margin of EXK has declined.
EXK's Gross Margin of 19.90% is in line compared to the rest of the industry. EXK outperforms 57.42% of its industry peers.
In the last couple of years the Gross Margin of EXK has declined.
Industry RankSector Rank
OM 4.23%
PM (TTM) N/A
GM 19.9%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXK is destroying value.
The number of shares outstanding for EXK has been increased compared to 1 year ago.
The number of shares outstanding for EXK has been increased compared to 5 years ago.
The debt/assets ratio for EXK is higher compared to a year ago.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

EXK has an Altman-Z score of 2.61. This is not the best score and indicates that EXK is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of EXK (2.61) is comparable to the rest of the industry.
EXK has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
EXK has a Debt to Equity ratio (0.25) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 2.61
ROIC/WACC0.15
WACC7.77%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

EXK has a Current Ratio of 1.14. This is a normal value and indicates that EXK is financially healthy and should not expect problems in meeting its short term obligations.
EXK has a worse Current ratio (1.14) than 81.29% of its industry peers.
A Quick Ratio of 0.77 indicates that EXK may have some problems paying its short term obligations.
EXK has a Quick ratio of 0.77. This is in the lower half of the industry: EXK underperforms 79.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.77
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

EXK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -900.00%.
The Revenue has been growing slightly by 1.72% in the past year.
EXK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.33% yearly.
EPS 1Y (TTM)-900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
Revenue 1Y (TTM)1.72%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%-0.36%

3.2 Future

The Earnings Per Share is expected to grow by 55.91% on average over the next years. This is a very strong growth
EXK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.76% yearly.
EPS Next Y342.4%
EPS Next 2Y179.42%
EPS Next 3Y74.85%
EPS Next 5Y55.91%
Revenue Next Year94.75%
Revenue Next 2Y70.46%
Revenue Next 3Y33.75%
Revenue Next 5Y28.76%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXK. In the last year negative earnings were reported.
EXK is valuated reasonably with a Price/Forward Earnings ratio of 10.35.
Based on the Price/Forward Earnings ratio, EXK is valued a bit cheaper than 74.84% of the companies in the same industry.
EXK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.13.
Industry RankSector Rank
PE N/A
Fwd PE 10.35
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXK.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 35.46
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXK's earnings are expected to grow with 74.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y179.42%
EPS Next 3Y74.85%

0

5. Dividend

5.1 Amount

No dividends for EXK!.
Industry RankSector Rank
Dividend Yield N/A

ENDEAVOUR SILVER CORP

NYSE:EXK (6/13/2025, 8:04:00 PM)

After market: 4.8 -0.01 (-0.21%)

4.81

+0.01 (+0.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners42.36%
Inst Owner Change5.08%
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap1.39B
Analysts78.18
Price Target6.12 (27.23%)
Short Float %7.44%
Short Ratio1.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2514.86%
Min EPS beat(2)-5248.51%
Max EPS beat(2)218.79%
EPS beat(4)1
Avg EPS beat(4)-1807.45%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-976.72%
EPS beat(12)2
Avg EPS beat(12)-706.48%
EPS beat(16)3
Avg EPS beat(16)-553.55%
Revenue beat(2)1
Avg Revenue beat(2)-8.29%
Min Revenue beat(2)-16.69%
Max Revenue beat(2)0.11%
Revenue beat(4)3
Avg Revenue beat(4)-2.31%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)6.54%
Revenue beat(8)5
Avg Revenue beat(8)-2.1%
Revenue beat(12)7
Avg Revenue beat(12)-1.99%
Revenue beat(16)8
Avg Revenue beat(16)-2.69%
PT rev (1m)0.35%
PT rev (3m)6.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)24.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.35
P/S 6.41
P/FCF N/A
P/OCF 77.83
P/B 3.08
P/tB 3.08
EV/EBITDA 35.46
EPS(TTM)-0.2
EYN/A
EPS(NY)0.46
Fwd EY9.66%
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)0.06
OCFY1.28%
SpS0.75
BVpS1.56
TBVpS1.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.68%
ROE -13.98%
ROCE 1.48%
ROIC 1.17%
ROICexc 1.31%
ROICexgc 1.31%
OM 4.23%
PM (TTM) N/A
GM 19.9%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexcg growth 3Y-31.89%
ROICexcg growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA 2.76
Cap/Depr 608.79%
Cap/Sales 88.35%
Interest Coverage 1.28
Cash Conversion 43.91%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.77
Altman-Z 2.61
F-Score3
WACC7.77%
ROIC/WACC0.15
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
EPS Next Y342.4%
EPS Next 2Y179.42%
EPS Next 3Y74.85%
EPS Next 5Y55.91%
Revenue 1Y (TTM)1.72%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%-0.36%
Revenue Next Year94.75%
Revenue Next 2Y70.46%
Revenue Next 3Y33.75%
Revenue Next 5Y28.76%
EBIT growth 1Y80.46%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year214.33%
EBIT Next 3Y84.98%
EBIT Next 5Y53.15%
FCF growth 1Y-105.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.55%
OCF growth 3Y-6.61%
OCF growth 5YN/A